Interferon beta (IFNB1) Rabbit Polyclonal Antibody

CAT#: AP05706PU-N

Interferon beta (IFNB1) rabbit polyclonal antibody, Purified


USD 425.00

5 Days*

Size
    • 100 ug

Product Images

Other products for "IFNB1"

Specifications

Product Data
Applications IHC, WB
Recommended Dilution Western blot: 5 µg/ml.
This Interferon beta antibody detects a band of approximately 15kDa in A20 cell lysates.
Immunohistochemistry on Paraffin Sections (requires antigen retrieval using heat treatment prior to staining).
Reactivities Human, Mouse
Host Rabbit
Isotype IgG
Clonality Polyclonal
Immunogen A 17 amino acid peptide located near the centre of human Interferon beta.
Specificity This antibody recognises interferon beta (IFN-beta), a 22kD member of the type I alpha/beta interferon family.
Formulation PBS
State: Purified
State: Liquid purified IgG fraction
Preservative: 0.02% Sodium Azide
Concentration lot specific
Purification Affinity Chromatography
Storage Store undiluted at 2-8°C for up to one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Stability Shelf life: one year from despatch.
Gene Name Homo sapiens interferon, beta 1, fibroblast (IFNB1)
Background The mammalian type I Inteferons (IFN1) are produced in response to viral infection and other inducers. They are divided into alpha and beta subtypes leukocytes and fibroblasts reactivity. The human IFN alphas are encoded by a family of at least 15 different genes, while IFN beta is the unique member of its subtype. There is approximately 50% amino acid homology between the alpha and beta subtypes. Both IFN subtypes are pleiotropic cytokines and have a similar range of biological activities. Differences between alpha subtypes, and between IFN alpha and betas, are in potency and cell type specific activities. In particular, IFN beta elicits a markedly higher antiproliferation response in some cell types such as, embryonal carcinoma, melanoma and melanocytes than do IFN alphas. Higher potency of IFN beta in treatment of multiple sclerosis and certain cancers has been observed. Type I IFNs signal through binding to a common cell surface receptor. Two chains of the receptor, IFNAR1 and IFNAR2, have been identified. Both chains are necessary for function and in the absence of either there is neither high affinity binding nor biological activity. The intracellular portions of the receptor subunits are bound by tyrosine kinases, Jak1 and Tyk2, members of the Janus kinase family. Upon ligand binding these kinases are activated and phosphorylate members of the STAT family of transcription factors, as well as IFNAR1 and 2.
Synonyms IFN-beta, IFNB1, IFB, Fibroblast interferon
Reference Data
Protein Families Druggable Genome, Secreted Protein, Transmembrane
Protein Pathways Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.